HROW Harrow, Inc. - Common Stock
$41.66
मूल्य · अग 19, 2026
मौलिकता इस प्रकार है अग 10, 2026
52W रेंज
$29–$55
50% of range
विश्लेषक रेटिंग
BUY
14 analysts
मूल्य लक्ष्य
$68
+62% upside
P/E (TTM)
-297.5
ROE
-8.4%
शुद्ध लाभ मार्जिन
-1.9%
Harrow, Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
और पढ़ें
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a $20 million Series A financing, and Eton is now a publicly traded company. In 2017, Harrow started Surface Pharmaceuticals, hiring Dr. Kamran Hosseini to be its chief executive officer. Surface was funded with a $20 million Series A financing with Flying L Partners leading the round. In 2018, Harrow started Melt Pharmaceuticals and announced an $11 million Series A financing.
In 2019, Harrow hired founder and former CEO of Doxy.me, Drew Livingston, as its chief innovation officer. Livingston is the senior executive of Harrow's Visionology.com telemedicine subsidiary.
Administration and drug pricing advocacy
The company's founder and chief executive officer is Mark L. Baum, a lawyer by training. Baum has been working in the HIV-related pharmacy field since 1999. Baum has been an advocate for drug pricing and patient advocacy, debating former US congressman James Greenwood on this issue at the Oxford Union debating society. In 2016, Baum authored a monograph on drug pricing and has written about pharmaceutical market monopolies in The Wall Street Journal.
Harrow, through its ImprimisRx subsidiary, has sought to create competition for drugs that companies have monopolies through regulatory or other means by marketing new formulations as a compounding pharmacy. This strategy would allow patient access to certain lower cost medication provided, among other conditions, a patient's physician believed such a formulation was best suited for a patient's needs.
In 2015, the company gained international attention when it compounded a pyrimethamine and leucovorin combination formulation which it argued may offer a low-cost, US$1 per pill, "alternative" to Daraprim, a medication which gained public attention after its price in the United States was increased by over 5,000 percent by Martin Shkreli and Turing Pharmaceuticals. In December 2015, Express Scripts accepted the company's product into its formulary.
In 2016, it introduced a lower cost version of tiopronin, and was said to have been working on a version of Mylan's EpiPen. The EpiPen competitor's price target was US$100 for a pair of injectors.
In October 2015, Anthony Principi, a former United States Secretary of Veterans Affairs, was elected to the company's board of directors.
ImprimisRx compounding business
Through its compounding subsidiary ImprimisRx, the company was the first pharmaceutical compounding company to make cGMP ophthalmic eye drops and other sterile compounded products available at a national scale through its FDA-registered outsourcing facility.
ImprimisRx's primary business is that of compounding drugs; that is, combining or altering the formulation of existing drugs to market them to specific populations. As of 2015, the company's business model was driven by development and sale of inexpensive alternatives to off-patent medicines where there was previously only a single manufacturer who could therefore charge outsize prices.
In August 2020, ImprimisRx announced that it was expanding its business beyond compounded drugs and that through a partnership with EyePoint Pharmaceuticals, it would begin to sell Dexycu, an FDA-approved steroid product.
As of 2020, Imprimis operated two pharmaceutical production and distribution facilities, both of which are located in Ledgewood, New Jersey. The company has licenses to operate federally, through the US DEA, and through state pharmacy boards in all 50 of the United States.
Litigation
In 2017, after launching a $49 per month low-cost compounded cyclosporine-A formulation as a potential competitor to Restasis and a glaucoma eye drop program called Simple Drops, the company, alongside Sinceres, became the target of a suit from Allergan for claims connected to supposed false and misleading marketing statements.
The company responded, calling Allergan a "professional litigant" and stating, "Allergan, one of the most powerful Big Pharma companies in the world, has filed this lawsuit against one of the smallest pharmaceutical companies in the world, to snuff out any competition to its high drug price strategies. Allergan, a true Goliath, is bent on ensuring that Americans continue to pay the highest possible prices for its drugs."
During the lawsuit, it was revealed that Allergan engaged in significant lobbying to FDA, state boards of pharmacy, and other federal and state agencies to complain about ImprimisRx. In December 2017, ImprimisRx received a warning letter from the FDA, relaying the agency's determination that the marketing of some of the company's eye drops contained false or misleading claims about efficacy and risks, allegedly in violation of federal law.
After a jury trial, Harrow (then Imprimis Pharmaceuticals) was ordered to pay $0 for disgorgement of profit and $48,500 for lost profit, despite Allergan having sought $60 million.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
HROW स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$41.66
मार्केट कैप
$1.55B
P/E (TTM)
-297.5
EPS (TTM)
$-0.14
राजस्व (TTM)
$272M
लाभांश प्रतिफल
—
ROE
-8.4%
D/E ऋण/इक्विटी
—
52W रेंज
$29 – $55
HROW स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
Configure
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व और शुद्ध आय
$272M
2016-12-31
→
2025-12-31
EPS
$-0.14
2017-12-31
→
2025-12-31
फ्री कैश फ्लो
$43M
2016-12-31
→
2025-12-31
मार्जिन
-1.9%
2016-12-31
→
2025-12-31
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
मेट्रिक
5Y रुझान
HROW
सहकर्मी माध्यिका
P/E (TTM)
-297.5
31.7
P/S (TTM)
5.7
5.1
P/B
29.6
4.8
Price / FCF (मूल्य / FCF)
36.1
—
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
मेट्रिक
5Y रुझान
HROW
सहकर्मी माध्यिका
Gross Margin (सकल मार्जिन)
75.0%
74.1%
Operating Margin (परिचालन मार्जिन)
11.2%
—
Net Profit Margin (शुद्ध लाभ मार्जिन)
-1.9%
-0.88%
ROA
-1.3%
-2.9%
ROE
-8.4%
-6.8%
ROIC
218.6%
—
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
मेट्रिक
5Y रुझान
HROW
सहकर्मी माध्यिका
Current Ratio (वर्तमान अनुपात)
2.2
4.7
Quick Ratio (त्वरित अनुपात)
1.9
—
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
मेट्रिक
5Y रुझान
HROW
सहकर्मी माध्यिका
Revenue YoY (राजस्व YoY)
36.4%
—
Revenue CAGR 3Y (राजस्व CAGR 3Y)
45.4%
—
Revenue CAGR 5Y (राजस्व CAGR 5Y)
41.0%
—
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
मेट्रिक
5Y रुझान
HROW
सहकर्मी माध्यिका
HROW विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
खरीदें
14 विश्लेषक
- मजबूत खरीद 5 35.7%
- खरीदें 8 57.1%
- होल्ड 1 7.1%
- बेचें 0 0.0%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
8 विश्लेषक · 2026-08-18
मध्यिका
$61.50
माध्य
$67.50
← सभी लक्ष्यों से नीचे
$41.66
निम्न
$59.00
उच्च
$88.00
मध्यिका लक्ष्य
$61.50
+47.6%
माध्य लक्ष्य
$67.50
+62.0%
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
-0.18%
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $-0.34 | $-0.18 | -0.16% |
| 31 मार्च 2026 | $-0.74 | $-0.41 | -0.33% |
| 31 दिसमबर 2025 | $0.17 | $0.38 | -0.21% |
| 30 सितमबर 2025 | $0.22 | $0.27 | -0.05% |
| 30 जून 2025 | $0.13 | $0.01 | 0.12% |
| 31 मार्च 2025 | $-0.50 | $-0.05 | -0.45% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| ETON | $457M | — | 104.9% | -5.8% | -18.4% | 53.5% |
| AVLN | — | — | — | — | — | — |
| MAZE | $2.04B | -13.6 | — | — | -598.9% | — |
| INVA | — | 6.1 | 14.7% | — | — | — |
| LBRX | $563M | -7.1 | — | — | -25.5% | — |
| XERS | $1.30B | — | 43.7% | 0.19% | -19.7% | — |
| PAHC | — | 21.5 | 27.4% | 3.7% | 17.8% | 30.9% |
| SPTX | — | — | — | — | — | — |
| ANRO | $568M | -8.1 | — | — | -46.1% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 18
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $272M | $200M | $130M | $89M | $72M | $49M | $51M | $41M | $27M | $20M | $10M | $2M | |
| Cost of Revenue | $68M | $49M | $40M | $25M | $18M | $14M | $17M | $17M | $14M | · | · | · | |
| Gross Profit | $204M | $150M | $91M | $63M | $54M | $34M | $34M | $25M | $13M | $10M | $5M | $567.0K | |
| R&D Expense | $21M | $12M | $7M | $3M | $11M | $2M | $2M | $825.0K | $413.0K | $739.0K | $332.0K | $237.0K | |
| SG&A Expense | $153M | $129M | $83M | $58M | $41M | $31M | $33M | $29M | $25M | $18M | $13M | $8M | |
| Operating Expenses | $174M | $142M | $90M | $61M | $53M | $34M | $39M | $30M | $25M | · | · | · | |
| Operating Income | $31M | $9M | $431.0K | $2M | $2M | $385.0K | $-5M | $-5M | $-12M | $-16M | $-15M | $-10M | |
| Interest Expense | · | · | $21M | $7M | $5M | · | · | · | · | · | · | $3.8K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $32.4K | |
| Other Non-op | $47.0K | $-185.0K | $-444.0K | $102.0K | $197.0K | $-73.0K | $630.0K | $103.0K | $-884.0K | $2M | $-1M | $29.0K | |
| Pretax Income | $-1M | $-17M | $-24M | $-14M | $-18M | $-3M | $-117.0K | $15M | $-13M | $-19M | · | · | |
| Income Tax | $4M | $161.0K | $701.0K | $75.0K | $133.0K | $4.0K | $8.0K | · | $-935.0K | $-111.0K | · | $3.0K | |
| Net Income | $-5M | $-17M | $-24M | $-14M | $-18M | $-3M | $168.0K | $15M | $-12M | $-19M | $-16M | $-10M | |
| EPS (Basic) | $-0.14 | $-0.49 | $-0.75 | $-0.51 | $-0.69 | $-0.13 | $0.01 | $0.67 | $-0.60 | · | · | · | |
| EPS (Diluted) | $-0.14 | $-0.49 | $-0.75 | $-0.51 | · | $-0.13 | $0.01 | $0.61 | $-0.60 | · | · | · | |
| Shares (Basic) | 36,760,461 | 35,650,714 | 32,616,777 | 27,460,968 | 26,757,451 | 25,895,352 | 25,323,159 | 21,917,570 | 20,027,712 | · | · | · | |
| Shares (Diluted) | 36,760,461 | 35,650,714 | 32,616,777 | 27,460,968 | · | 25,895,352 | 26,466,098 | 23,812,045 | 20,027,712 | · | · | · | |
| EBITDA | $32M | $10M | $1M | $3M | $3M | $2M | $-5M | $-5M | $-12M | $-16M | $-15M | $-10M |
बैलेंस शीट 27
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $73M | $47M | $74M | $96M | $42M | $4M | $5M | · | $4M | $9M | $3M | $8M | |
| Short-term Investments | · | · | $9M | $6M | $9M | $28M | · | · | · | · | · | · | |
| Receivables | $111M | $116M | $36M | $6M | $4M | $3M | $2M | $2M | $2M | $3M | $840.0K | $81.0K | |
| Inventory | $14M | $11M | $11M | $7M | $4M | $4M | $3M | $2M | $2M | $2M | $1M | $373.0K | |
| Prepaid Expense | $14M | $15M | $10M | $4M | $1M | $2M | $586.0K | $837.0K | $714.0K | $938.0K | $786.0K | $241.0K | |
| Other Current Assets | $2M | $3M | $2M | $118.0K | $92.0K | $190.0K | $105.0K | $125.0K | $124.0K | $106.0K | $119.0K | $35.0K | |
| Current Assets | $212M | $190M | $139M | $118M | $61M | $41M | $36M | $33M | $9M | $15M | $6M | $9M | |
| PP&E (Net) | $3M | $4M | $4M | $3M | $3M | $4M | $5M | $6M | $6M | $7M | $3M | $243.0K | |
| PP&E (Gross) | $15M | $15M | $14M | $13M | $11M | $10M | $11M | $11M | $9M | $9M | $3M | $288.0K | |
| Accum. Depreciation | $12M | $11M | $10M | $9M | $8M | $6M | $5M | $4M | $3M | $1M | $300.0K | $45.0K | |
| Goodwill | $332.0K | $332.0K | $332.0K | $332.0K | $332.0K | $332.0K | $332.0K | $2M | $2M | $2M | $2M | $332.0K | |
| Intangibles | $175M | $185M | $160M | $24M | $16M | $2M | $2M | $3M | $3M | $3M | $3M | $611.0K | |
| Total Assets | $399M | $389M | $312M | $157M | $98M | $57M | $59M | $49M | $24M | $27M | $14M | $10M | |
| Accounts Payable | $35M | $39M | $25M | $14M | $6M | $4M | $8M | $6M | $4M | $4M | $3M | $787.0K | |
| Short-term Debt | · | $220M | · | · | · | $4M | $2M | $3M | · | $4M | · | · | |
| Current Liabilities | $96M | $91M | $49M | $19M | $10M | $11M | $12M | $12M | $6M | $10M | $5M | $2M | |
| Capital Leases | $8M | $9M | $7M | $7M | $6M | $7M | $6M | · | $720.0K | $1M | $1.0K | $19.0K | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $936.0K | $1M | · | |
| Total Liabilities | $347M | $320M | $242M | $130M | $87M | $31M | $32M | $25M | $21M | $21M | $16M | $2M | |
| Long-term Debt | $250M | $263M | $247M | $152M | $103M | $20M | · | $23M | $23M | · | · | · | |
| Total Debt | · | · | · | · | · | $3M | $2M | $3M | · | $4M | · | · | |
| Common Stock | $37.0K | $35.0K | $35.0K | $30.0K | $27.0K | $26.0K | $26.0K | $24.0K | $21.0K | $19.0K | $10.0K | $9.0K | |
| Paid-in Capital | $209M | $221M | $205M | $137M | $107M | $105M | $102M | $99M | $91M | $83M | · | · | |
| Retained Earnings | $-157M | $-151M | $-134M | $-109M | $-95M | $-77M | $-74M | $-74M | $-89M | $-77M | $-58M | $-42M | |
| Stockholders' Equity | $52M | $70M | $71M | $28M | $11M | $27M | $28M | $25M | $3M | $6M | $-1M | $8M | |
| Liabilities + Equity | $399M | $389M | $312M | $157M | $98M | $57M | $59M | $49M | $24M | $27M | $14M | $10M | |
| Shares Outstanding | 37,229,159 | 35,622,214 | 35,168,260 | 29,901,530 | 26,902,763 | 25,749,875 | 25,526,931 | 24,339,610 | 20,623,129 | 18,627,915 | 9,755,678 | 9,258,231 |
नकदी प्रवाह 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $255.0K | $37.0K | |
| Stock-based Comp | $13M | $18M | $16M | $8M | $6M | $3M | $2M | $2M | $3M | $4M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | · | $0 | $-935.0K | $-111.0K | · | · | |
| Amort. of Intangibles | $17M | $12M | $10M | $2M | $161.0K | $167.0K | $209.0K | $235.0K | $364.0K | $351.0K | $355.0K | $48.0K | |
| Other Non-cash | $35M | $-24M | $12M | $7M | $16M | $-2M | · | · | · | · | · | · | |
| Operating Cash Flow | $44M | $-22M | $4M | $2M | $5M | $-1M | $950.0K | $687.0K | $-9M | $-11M | $-11M | $-7M | |
| CapEx | $887.0K | $2M | $1M | $3M | $2M | $862.0K | $1M | $2M | $772.0K | $7M | $-995.0K | $174.0K | |
| Investing Cash Flow | $-5M | $-33M | $-153M | $-2M | $-19M | $-981.0K | $-2M | $-2M | $-961.0K | $-7M | $-5M | $-910.0K | |
| Stock Issued | · | · | $65M | $23M | · | · | · | $642.0K | $1M | $212.0K | $404.0K | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $-13.0K | |
| Net Stock Activity | · | · | · | $23M | · | · | · | $642.0K | $1M | $212.0K | $404.0K | $-13.1K | |
| Financing Cash Flow | $-13M | $29M | $127M | $54M | $51M | $1M | $-1M | $4M | $5M | $25M | $11M | $599.0K | |
| Net Change in Cash | $26M | $-27M | $-22M | $54M | $38M | $-648.0K | $-2M | $3M | $-5M | $6M | $-6M | $-7M | |
| Taxes Paid | $93.0K | $374.0K | · | $75.0K | $11.0K | $4.0K | $17.0K | $4.0K | $9.0K | $9.0K | $1.0K | $1.0K | |
| Free Cash Flow | $43M | $-24M | $2M | $-892.0K | $3M | $-2M | $-518.0K | $-1M | $-10M | $-4M | $-12M | $-7M | |
| Levered FCF | · | · | $-20M | $-8M | · | · | · | · | · | · | · | · |
लाभप्रदता 8
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.0% | 75.3% | 69.5% | 71.4% | 74.9% | 70.4% | 67.3% | 60.1% | 49.6% | 50.7% | 46.4% | 34.2% | |
| Operating Margin | 11.2% | 4.4% | 0.33% | 2.2% | 2.2% | 0.79% | -9.4% | -12.6% | -45.4% | -79.6% | -152.6% | -611.2% | |
| Net Margin | -1.9% | -8.8% | -18.8% | -15.9% | -24.9% | -6.9% | 0.33% | 35.4% | -44.8% | -95.7% | -163.6% | -609.4% | |
| Pretax Margin | -0.50% | -8.7% | -18.2% | -15.8% | -24.7% | -7.0% | -0.24% | 35.4% | -48.3% | · | · | · | |
| EBITDA Margin | 11.7% | 5.1% | 1.1% | 3.6% | 4.4% | 4.6% | -9.4% | -12.6% | -45.4% | -79.6% | -152.6% | -611.2% | |
| ROA | -1.3% | -5.0% | -10.4% | -11.0% | -23.1% | -5.8% | 0.31% | 39.9% | -46.9% | -92.3% | -130.5% | -77.8% | |
| ROE | -8.4% | -24.9% | -49.6% | -72.5% | -93.6% | -12.2% | 0.64% | 117.8% | -265.0% | -756.4% | -470.0% | -87.0% | |
| ROIC | 218.6% | 12.8% | 0.63% | 7.0% | 14.4% | 1.3% | · | · | -431.5% | · | · | · |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 2.1 | 2.8 | 6.3 | 6.2 | 3.7 | 3.0 | 2.8 | 1.5 | 1.5 | 1.1 | 5.8 | |
| Quick Ratio | 1.9 | 1.8 | 2.4 | 0.6 | 4.8 | 0.6 | 0.2 | 0.2 | 1.0 | 1.2 | 0.7 | 5.3 | |
| Debt / Equity | · | · | · | · | · | 0.1 | 0.1 | 0.1 | · | 0.6 | · | · | |
| Interest Coverage | · | · | 0.0 | 0.3 | · | · | · | · | · | · | · | -2670.2 |
दक्षता 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.7 | 0.9 | 0.8 | 0.9 | 1.1 | 1.0 | 1.0 | 0.8 | 0.1 | |
| Inventory Turnover | 5.6 | 4.6 | 4.6 | 4.7 | 4.5 | 4.0 | 6.5 | 8.1 | · | · | · | · | |
| Receivables Turnover | 2.4 | 2.6 | 6.1 | 16.5 | 20.3 | 20.9 | 26.1 | 24.0 | 12.0 | 10.6 | 21.1 | 40.8 |
विकास दरें 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 36.4% | 53.3% | 46.9% | 22.2% | 48.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 45.4% | 40.2% | 38.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 41.0% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 14
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $272M | $200M | $130M | $89M | $72M | $49M | $51M | $41M | $27M | $20M | $10M | $2M | |
| Net Income TTM | $-5M | $-17M | $-24M | $-14M | $-18M | $-3M | $168.0K | $15M | $-12M | $-19M | $-16M | $-10M | |
| Market Cap | $1.82B | $1.20B | $394M | $441M | $232M | $177M | $199M | $138M | $35M | $47M | $68M | $69M | |
| Enterprise Value | · | · | · | · | · | $175M | · | · | · | $42M | · | · | |
| P/E | -350.0 | -68.5 | -14.9 | -28.9 | · | -52.8 | 778.0 | 9.3 | -2.8 | · | · | · | |
| P/S | 6.7 | 6.0 | 3.0 | 5.0 | 3.2 | 3.6 | 3.9 | 3.3 | 1.3 | 2.3 | 7.0 | 41.8 | |
| P/B | 34.8 | 17.2 | 5.6 | 16.0 | 20.6 | 6.5 | 7.2 | 5.6 | 13.4 | 7.2 | -48.8 | 8.5 | |
| P / Tangible Book | · | · | · | 124.7 | · | 7.1 | · | · | · | · | · | · | |
| P / Cash Flow | 41.6 | -53.8 | 102.6 | 258.9 | 45.7 | -160.6 | 209.1 | 201.6 | -4.0 | -4.2 | -6.1 | -9.8 | |
| P / FCF | 42.4 | -50.2 | 165.5 | -494.8 | 70.5 | -90.0 | -383.4 | -128.1 | -3.7 | -10.8 | -5.6 | -9.6 | |
| EV / EBITDA | · | · | · | · | · | 77.3 | · | · | · | -2.6 | · | · | |
| EV / FCF | · | · | · | · | · | -89.3 | · | · | · | -9.6 | · | · | |
| EV / Revenue | · | · | · | · | · | 3.6 | · | · | · | 2.1 | · | · | |
| Earnings Yield | -0.29% | -1.5% | -6.7% | -3.5% | · | -1.9% | 0.13% | 10.7% | -35.3% | · | · | · |
आय विवरण 17
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71M | $44M | $89M | $72M | $64M | $48M | $67M | $49M | $49M | $35M | $36M | $34M | $33M | $26M | $20M | $23M | |
| Cost of Revenue | $20M | $17M | $18M | $18M | $16M | $16M | $14M | $12M | $13M | $11M | $11M | $10M | $10M | $8M | $6M | $7M | |
| Gross Profit | $50M | $27M | $71M | $54M | $48M | $32M | $53M | $37M | $36M | $24M | $25M | $24M | $23M | $18M | $14M | $16M | |
| R&D Expense | $8M | $6M | $12M | $3M | $3M | $3M | $5M | $2M | $3M | $2M | $3M | $1M | $1M | $734.0K | $703.0K | $775.0K | |
| SG&A Expense | $53M | $43M | $43M | $36M | $33M | $41M | $35M | $34M | $32M | $29M | $26M | $21M | $20M | $16M | $15M | $15M | |
| Operating Expenses | $61M | $49M | $55M | $39M | $36M | $44M | $40M | $36M | $35M | $31M | $30M | $22M | $21M | $17M | $16M | $16M | |
| Operating Income | $-11M | $-22M | $16M | $15M | $11M | $-11M | $13M | $1M | $2M | $-7M | $-5M | $2M | $2M | $1M | $-2M | $-94.0K | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $6M | $6M | $5M | $2M | $2M | |
| Other Non-op | $0 | · | $7M | $61.0K | $-6.0K | $-7M | $6M | $4.0K | $46.0K | $-7M | $-100.0K | $-195.0K | $-178.0K | $29.0K | · | · | |
| Pretax Income | $-17M | $-28M | $10M | $1M | $5M | $-18M | $6M | $-4M | $-6M | $-14M | $-10M | $-3M | $-4M | $-7M | $1M | $-6M | |
| Income Tax | $0 | $25.0K | · | · | $0 | · | $-514.0K | $20.0K | $655.0K | · | $-535.0K | $2M | $-15.0K | $-288.0K | $0 | $35.0K | |
| Net Income | $-17M | $-28M | $7M | $1M | $5M | $-18M | $7M | $-4M | $-6M | $-14M | $-9M | $-4M | $-4M | $-7M | $1M | $-6M | |
| EPS (Basic) | $-0.46 | $-0.74 | $0.19 | $0.03 | $0.14 | $-0.50 | $0.19 | $-0.12 | $-0.18 | $-0.38 | $-0.26 | $-0.13 | $-0.14 | $-0.22 | $0.05 | $-0.24 | |
| EPS (Diluted) | $-0.46 | $-0.74 | $0.20 | $0.03 | $0.13 | $-0.50 | $0.19 | $-0.12 | $-0.18 | $-0.38 | $-0.26 | $-0.13 | $-0.14 | $-0.22 | $0.05 | $-0.24 | |
| Shares (Basic) | 37,350,401 | 37,231,321 | -73,001,737 | 37,145,440 | 36,790,306 | 35,826,452 | -71,140,101 | 35,702,200 | 35,618,977 | 35,469,638 | -62,386,827 | 34,255,197 | 30,458,677 | 30,289,730 | -54,418,951 | 27,349,642 | |
| Shares (Diluted) | 37,350,401 | 37,231,321 | -76,794,851 | 38,875,005 | 38,853,855 | 35,826,452 | -71,140,101 | 35,702,200 | 35,618,977 | 35,469,638 | -62,386,827 | 34,255,197 | 30,458,677 | 30,289,730 | -54,418,951 | 27,349,642 | |
| EBITDA | $-11M | $-22M | · | $15M | $12M | $-11M | · | $1M | $2M | $-7M | · | $2M | $2M | $1M | · | $-94.0K |
बैलेंस शीट 27
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $84M | $95M | $73M | $74M | $53M | $67M | $47M | $73M | $71M | $69M | · | $66M | · | · | $96M | $45M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | $7M | · | $8M | $7M | $8M | $6M | $4M | |
| Receivables | $119M | $101M | $111M | $78M | $79M | $77M | $116M | $54M | $52M | $29M | · | $18M | $18M | $12M | $6M | $7M | |
| Inventory | $17M | $16M | $14M | $13M | $12M | $11M | $11M | $10M | $9M | $11M | · | $9M | $9M | $9M | $7M | $5M | |
| Prepaid Expense | $10M | $14M | $14M | $13M | $12M | $15M | $15M | $11M | $7M | $10M | · | $9M | $4M | $4M | $4M | $3M | |
| Other Current Assets | $1M | $1M | $2M | $3M | $3M | $3M | $3M | $1M | $1M | $2M | · | $118.0K | $427.0K | $118.0K | $118.0K | $73.0K | |
| Current Assets | $229M | $226M | $212M | $178M | $155M | $170M | $190M | $147M | $139M | $125M | · | $110M | $60M | $52M | $118M | $64M | |
| PP&E (Net) | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | · | $4M | $4M | $4M | $3M | $3M | |
| PP&E (Gross) | · | · | $15M | $15M | $15M | $15M | $15M | $15M | $14M | $14M | · | $13M | $13M | $13M | $13M | $12M | |
| Accum. Depreciation | · | · | $12M | $12M | $12M | $11M | $11M | $11M | $11M | $10M | · | $10M | $10M | $9M | $9M | $9M | |
| Goodwill | $332.0K | $332.0K | $332.0K | $332.0K | $332.0K | $332.0K | $332.0K | $332.0K | $332.0K | $332.0K | · | $332.0K | $332.0K | $332.0K | $332.0K | $332.0K | |
| Intangibles | $176M | $181M | $175M | $172M | $177M | $181M | $185M | $189M | $155M | $157M | · | $163M | $150M | $152M | $24M | $20M | |
| Total Assets | $417M | $420M | $399M | $363M | $345M | $364M | $389M | $352M | $307M | $296M | · | $286M | $224M | $217M | $157M | $99M | |
| Accounts Payable | $26M | $26M | $35M | $19M | $23M | $37M | $39M | $25M | $22M | $15M | · | $13M | $18M | $14M | $14M | $14M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $59.0K | · | · | · | · | |
| Short-term Debt | · | · | · | $243M | $184M | $108M | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $102M | $91M | $96M | $65M | $249M | $187M | $91M | $95M | $54M | $42M | · | $19M | $23M | $18M | $19M | $18M | |
| Capital Leases | $7M | $8M | $8M | $8M | $8M | $9M | $9M | $10M | $7M | $7M | · | $7M | $7M | $7M | $7M | $8M | |
| Total Liabilities | $402M | $391M | $347M | $316M | $296M | $308M | $320M | $294M | $248M | $235M | · | $211M | $202M | $196M | $130M | $98M | |
| Long-term Debt | · | $300M | $250M | $347M | $251M | $257M | · | $231M | $236M | $243M | · | $252M | $240M | $244M | · | $98M | |
| Total Debt | · | · | · | $243M | $184M | $108M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $37.0K | $37.0K | $37.0K | $37.0K | $36.0K | $35.0K | $35.0K | $35.0K | $35.0K | $35.0K | · | $35.0K | $30.0K | $30.0K | $30.0K | $27.0K | |
| Paid-in Capital | $217M | $213M | $209M | $210M | $214M | $226M | $221M | $216M | $212M | $208M | · | $200M | $143M | $138M | $137M | $112M | |
| Retained Earnings | $-201M | $-184M | $-157M | $-163M | $-164M | $-169M | $-151M | $-158M | $-154M | $-147M | · | $-125M | $-120M | $-116M | $-109M | $-111M | |
| Stockholders' Equity | $15M | $29M | $52M | $47M | $50M | $56M | $70M | $58M | $59M | $61M | · | $76M | $22M | $22M | $28M | $1M | |
| Liabilities + Equity | $417M | $420M | $399M | $363M | $345M | $364M | $389M | $352M | $307M | $296M | · | $286M | $224M | $217M | $157M | $99M | |
| Shares Outstanding | 37,484,233 | 37,269,400 | 37,229,159 | 37,034,582 | 36,714,679 | 35,654,171 | 35,622,214 | 35,611,365 | 35,479,492 | 35,380,955 | · | 35,117,621 | 30,276,938 | 30,056,370 | 29,901,530 | 27,074,307 |
नकदी प्रवाह 13
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $460.0K | $455.0K | $330.0K | $326.0K | $347.0K | $312.0K | $321.0K | $351.0K | $301.0K | $296.0K | $435.0K | $405.0K | $398.0K | $225.0K | $387.0K | $247.0K | |
| Stock-based Comp | $4M | $4M | $4M | $3M | $875.0K | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $2M | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | $20.0K | · | · | · | · | $0 | $-288.0K | · | · | |
| Amort. of Intangibles | $6M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $3M | $3M | $2M | $378.0K | $398.0K | |
| Other Non-cash | · | · | · | · | · | $33M | · | · | · | $4M | · | · | · | · | · | · | |
| Operating Cash Flow | $-10M | $-9M | $8M | $17M | $-803.0K | $20M | $-18M | $3M | $-3M | $-5M | $9M | $-1M | $5M | $-8M | $-4M | $-410.0K | |
| CapEx | $491.0K | $194.0K | $341.0K | $210.0K | $166.0K | $170.0K | $555.0K | $604.0K | $344.0K | $92.0K | $194.0K | $520.0K | $250.0K | $496.0K | $878.0K | $1M | |
| Investing Cash Flow | $-534.0K | $-18M | $-5M | $-225.0K | $-293.0K | $-212.0K | $-38M | $-597.0K | $5M | $-110.0K | $-203.0K | $-20M | $-1M | $-131M | $-5.0K | $-1M | |
| Financing Cash Flow | $-466.0K | $49M | $-5M | $5M | $-13M | $23.0K | $30M | $-721.0K | $73.0K | $-809.0K | $-18.0K | $64M | $189.0K | $62M | $55M | $0 | |
| Net Change in Cash | $-11M | $22M | $-1M | $21M | $-14M | $19M | $-25M | $2M | $2M | $-6M | $8M | $43M | $4M | $-77M | $51M | $-1M | |
| Taxes Paid | · | · | $55.0K | $0 | $0 | $38.0K | · | · | · | · | · | · | · | · | $0 | $35.0K | |
| Free Cash Flow | · | $-9M | · | · | · | $19M | · | · | · | $-5M | · | · | · | $-9M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-13M | · | · |
लाभप्रदता 8
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.3% | 61.2% | · | 75.3% | 74.5% | 67.5% | · | 75.6% | 74.4% | 69.5% | · | 70.6% | 70.1% | 68.3% | · | 70.5% | |
| Operating Margin | -15.6% | -50.0% | · | 20.6% | 17.9% | -23.5% | · | 2.7% | 3.1% | -20.0% | · | 5.1% | 7.0% | 4.6% | · | -0.41% | |
| Net Margin | -24.4% | -62.4% | · | 1.4% | 7.8% | -37.2% | · | -8.6% | -13.2% | -39.2% | · | -12.8% | -12.6% | -25.4% | · | -28.3% | |
| Pretax Margin | -24.4% | -62.4% | · | 1.4% | 7.8% | · | · | -8.5% | -11.9% | -39.2% | · | -8.3% | -12.7% | -26.6% | · | -28.2% | |
| EBITDA Margin | -15.6% | -50.0% | · | 21.0% | 18.4% | -22.8% | · | 2.7% | 3.1% | -19.2% | · | 5.1% | 7.0% | 4.6% | · | -0.41% | |
| ROA | -4.5% | -7.0% | · | 0.29% | 1.5% | -5.4% | · | -1.3% | -2.4% | -5.3% | · | -2.3% | -2.6% | -4.2% | · | -6.4% | |
| ROE | -53.3% | -64.8% | · | 1.9% | 9.2% | -30.4% | · | -6.3% | -16.0% | -32.9% | · | -11.4% | -30.0% | -41.5% | · | -72.6% | |
| ROIC | -72.4% | -77.0% | · | · | · | · | · | 2.3% | 2.9% | · | · | 3.5% | 10.5% | 5.3% | · | -7.8% |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 2.5 | · | 2.7 | 0.6 | 0.9 | · | 1.5 | 2.6 | 3.0 | · | 5.8 | 2.6 | 2.9 | · | 3.5 | |
| Quick Ratio | 2.0 | 2.1 | · | 2.3 | 0.5 | 0.8 | · | 1.3 | 2.3 | 2.5 | · | 4.9 | 1.1 | 1.1 | · | 3.0 | |
| Debt / Equity | · | · | · | 5.2 | 3.7 | 1.9 | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -1.3 | · | 0.3 | 0.4 | 0.3 | · | -0.1 |
दक्षता 3
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.3 | 1.4 | 1.1 | · | 1.4 | 1.5 | 1.2 | · | 1.5 | |
| Receivables Turnover | 0.7 | 0.5 | · | 1.1 | 1.0 | 0.9 | · | 1.4 | 1.4 | 1.7 | · | 2.7 | 2.7 | 2.9 | · | 4.2 |
मूल्यांकन (TTM) 13
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $250M | $227M | · | $232M | $210M | $181M | · | $167M | $151M | $128M | · | $117M | $106M | $94M | · | $87M | |
| Net Income TTM | $-39M | $-39M | · | $-16M | $-23M | $-42M | · | $-29M | $-29M | $-29M | · | $-22M | $-24M | $-22M | · | $-23M | |
| Market Cap | $1.59B | $1.31B | · | $1.78B | $1.12B | $948M | · | $1.60B | $741M | $468M | · | $505M | $576M | $636M | · | $327M | |
| Enterprise Value | · | · | · | $1.95B | $1.25B | $990M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -40.8 | -32.6 | · | -104.7 | -45.6 | -22.5 | · | -55.5 | -25.2 | -15.2 | · | -19.7 | -22.9 | -27.1 | · | -13.9 | |
| P/S | 6.4 | 5.8 | · | 7.7 | 5.3 | 5.3 | · | 9.6 | 4.9 | 3.6 | · | 4.3 | 5.5 | 6.7 | · | 3.8 | |
| P/B | 104.7 | 45.8 | · | 38.0 | 22.6 | 16.8 | · | 27.6 | 12.7 | 7.7 | · | 6.7 | 25.7 | 29.1 | · | 268.5 | |
| P / Cash Flow | · | -146.1 | · | · | · | 48.2 | · | · | · | -101.1 | · | · | · | -77.4 | · | · | |
| P / FCF | · | -143.1 | · | · | · | 48.6 | · | · | · | -99.2 | · | · | · | -73.0 | · | · | |
| EV / EBITDA | · | · | · | 129.6 | 106.5 | -90.7 | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | 50.8 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 8.4 | 6.0 | 5.5 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -2.5% | -3.1% | · | -0.95% | -2.2% | -4.4% | · | -1.8% | -4.0% | -6.6% | · | -5.1% | -4.4% | -3.7% | · | -7.2% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $272M | $200M | $130M | $89M | $72M |
| सकल मार्जिन % | 75.0% | 75.3% | 69.5% | 71.4% | 74.9% |
| परिचालन मार्जिन % | 11.2% | 4.4% | 0.33% | 2.2% | 2.2% |
| शुद्ध आय | $-5M | $-17M | $-24M | $-14M | $-18M |
| तनुकरणित EPS | $-0.14 | $-0.49 | $-0.75 | $-0.51 | — |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 2.2 | 2.1 | 2.8 | 6.3 | 6.2 |
| त्वरित अनुपात | 1.9 | 1.8 | 2.4 | 0.6 | 4.8 |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $43M | $-24M | $2M | $-892.0K | $3M |
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
📊
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 244 फाइलर्स · $773.6M कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 48 (+8 पिछली तिमाही की तुलना में) | 34 (+4 पिछली तिमाही की तुलना में) | 74 (+1 पिछली तिमाही की तुलना में) | 67 (-4 पिछली तिमाही की तुलना में) | +1.8M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| Opaleye Management Inc. | $101928000 | 2400000 | 13.18% | शेयर |
| Private Capital Management, LLC | $67899762 | 1598770 | 8.78% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $60188994 | 1417212 | 7.78% | शेयर |
| Deep Track Capital, LP | $41153430 | 969000 | 5.32% | शेयर |
| STATE STREET CORP | $39917043 | 939888 | 5.16% | शेयर |
| BAMCO INC /NY/ | $34373094 | 809350 | 4.44% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $33342270 | 784905 | 4.31% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $31550963 | 742900 | 4.08% | कॉल ऑप्शन |
| DIMENSIONAL FUND ADVISORS LP | $26788590 | 630765 | 3.46% | शेयर |
| Divisadero Street Capital Management, LP | $18650913 | 439155 | 2.41% | शेयर |
| CITADEL ADVISORS LLC | $16622758 | 391400 | 2.15% | कॉल ऑप्शन |
| RICE HALL JAMES & ASSOCIATES, LLC | $16459036 | 387545 | 2.13% | शेयर |
| Schonfeld Strategic Advisors LLC | $13574473 | 319625 | 1.75% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13531367 | 318610 | 1.75% | शेयर |
| MARSHALL WACE, LLP | $12157037 | 286250 | 1.57% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11623869 | 273696 | 1.50% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $9998202 | 235418 | 1.29% | शेयर |
| CITADEL ADVISORS LLC | $9895510 | 233000 | 1.28% | पुट ऑप्शन |
| Westside Investment Management, Inc. | $9473007 | 223051 | 1.22% | शेयर |
| FirstWave Capital Management LLC | $9002833 | 211981 | 1.16% | शेयर |
| Blackhawk Capital Partners, LLC | $8631645 | 203241 | 1.12% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8074227 | 190116 | 1.04% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7827221 | 184300 | 1.01% | पुट ऑप्शन |
| JANE STREET GROUP, LLC | $7772010 | 183000 | 1.00% | कॉल ऑप्शन |
| ROYCE & ASSOCIATES LP | $6565310 | 154587 | 0.85% | शेयर |
| Ikarian Capital, LLC | $5766364 | 135775 | 0.75% | शेयर |
| Advantage Alpha Capital Partners LP | $5374624 | 111553 | 0.69% | शेयर |
| Diametric Capital, LP | $4965082 | 116908 | 0.64% | शेयर |
| WOODMONT INVESTMENT COUNSEL LLC | $4748571 | 111810 | 0.61% | शेयर |
| FIRST TRUST ADVISORS LP | $4260378 | 100315 | 0.55% | शेयर |
| STATE OF WISCONSIN INVESTMENT BOARD | $4146219 | 97627 | 0.54% | शेयर |
| 12th Street Asset Management Company, LLC | $3882140 | 91409 | 0.50% | शेयर |
| Lumbard & Kellner, LLC | $3835975 | 90322 | 0.50% | शेयर |
| Steward Partners Investment Advisory, LLC | $3832960 | 90251 | 0.50% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $3575210 | 84182 | 0.46% | शेयर |
| EQUITABLE TRUST CO | $3371184 | 79378 | 0.44% | शेयर |
| BANK OF AMERICA CORP /DE/ | $3138533 | 73900 | 0.41% | शेयर |
| Squarepoint Ops LLC | $3126726 | 73622 | 0.40% | शेयर |
| KENNEDY CAPITAL MANAGEMENT LLC | $3004668 | 70748 | 0.39% | शेयर |
| Swiss National Bank | $2696845 | 63500 | 0.35% | शेयर |
| CITADEL ADVISORS LLC | $2533888 | 59663 | 0.33% | शेयर |
| Jefferson Bridge Capital, LLC | $2427925 | 57168 | 0.31% | शेयर |
| CAPTRUST FINANCIAL ADVISORS | $2395903 | 56414 | 0.31% | शेयर |
| Militia Capital Partners, LP | $2303000 | 47000 | 0.30% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $2288921 | 53895 | 0.30% | शेयर |
| GROUP ONE TRADING LLC | $2085914 | 49115 | 0.27% | शेयर |
| LJI Wealth Management, LLC | $2021572 | 47600 | 0.26% | शेयर |
| JANE STREET GROUP, LLC | $2000337 | 47100 | 0.26% | पुट ऑप्शन |
| RENAISSANCE TECHNOLOGIES LLC | $1894884 | 44617 | 0.24% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1863796 | 43885 | 0.24% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $1841542 | 43361 | 0.24% | शेयर |
| RHUMBLINE ADVISERS | $1739772 | 40965 | 0.22% | शेयर |
| BARD ASSOCIATES INC | $1716171 | 40409 | 0.22% | शेयर |
| BLAIR WILLIAM & CO/IL | $1693704 | 39880 | 0.22% | शेयर |
| LPL Financial LLC | $1547267 | 36432 | 0.20% | शेयर |
| Campbell & CO Investment Adviser LLC | $1541066 | 36286 | 0.20% | शेयर |
| D.A. DAVIDSON & CO. | $1471586 | 34650 | 0.19% | शेयर |
| BOOTHBAY FUND MANAGEMENT, LLC | $1417351 | 33373 | 0.18% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $1390549 | 39437 | 0.18% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1375810 | 39019 | 0.18% | शेयर |
| STANSBERRY ASSET MANAGEMENT, LLC | $1360399 | 32032 | 0.18% | शेयर |
| GOLDMAN SACHS GROUP INC | $1330713 | 31333 | 0.17% | शेयर |
| Brookstone Capital Management | $1323068 | 31153 | 0.17% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $1273208 | 29979 | 0.16% | शेयर |
| GREAT LAKES ADVISORS, LLC | $1145119 | 26963 | 0.15% | शेयर |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $1117556 | 26314 | 0.14% | शेयर |
| BlackRock, Inc. | $1115899 | 26275 | 0.14% | शेयर |
| Crawford Fund Management, LLC | $1113563 | 26220 | 0.14% | शेयर |
| Bank of New York Mellon Corp | $1109571 | 26126 | 0.14% | शेयर |
| OSAIC HOLDINGS, INC. | $1066373 | 25109 | 0.14% | शेयर |
| ENVESTNET ASSET MANAGEMENT INC | $1063406 | 25039 | 0.14% | शेयर |
| ExodusPoint Capital Management, LP | $1029600 | 24243 | 0.13% | शेयर |
| Bleakley Financial Group, LLC | $1022125 | 24067 | 0.13% | शेयर |
| Birchview Capital, LP | $1019280 | 24000 | 0.13% | शेयर |
| XTX Topco Ltd | $983053 | 23147 | 0.13% | शेयर |
| Focus Partners Wealth | $979826 | 23071 | 0.13% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $954556 | 22476 | 0.12% | शेयर |
| COMMERCE BANK | $952602 | 22430 | 0.12% | शेयर |
| Squarepoint Ops LLC | $925846 | 21800 | 0.12% | पुट ऑप्शन |
| VANGUARD ASSET MANAGEMENT, Ltd | $904399 | 21295 | 0.12% | शेयर |
| IMC-Chicago, LLC | $886646 | 20877 | 0.11% | शेयर |
| FineMark National Bank & Trust | $854070 | 17430 | 0.11% | शेयर |
| Sonora Investment Management Group, LLC | $826191 | 17148 | 0.11% | शेयर |
| CORSAIR CAPITAL MANAGEMENT, L.P. | $806930 | 19000 | 0.10% | शेयर |
| MetLife Investment Management, LLC | $803023 | 18908 | 0.10% | शेयर |
| Private Capital Management, LLC | $743225 | 17500 | 0.10% | कॉल ऑप्शन |
| Round Rock Advisors LLC | $742418 | 17481 | 0.10% | शेयर |
| MML INVESTORS SERVICES, LLC | $707805 | 16666 | 0.09% | शेयर |
| Lido Advisors, LLC | $700288 | 16489 | 0.09% | शेयर |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $692091 | 16296 | 0.09% | शेयर |
| Atria Investments, Inc | $683215 | 16087 | 0.09% | शेयर |
| UBS Group AG | $672640 | 15838 | 0.09% | शेयर |
| BARCLAYS PLC | $672215 | 15828 | 0.09% | शेयर |
| SIMPLEX TRADING, LLC | $651872 | 15349 | 0.08% | शेयर |
| ARISTEIA CAPITAL, L.L.C. | $651702 | 15345 | 0.08% | शेयर |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $633270 | 14911 | 0.08% | शेयर |
| VANGUARD GROUP INC | $617155 | 12595 | 0.08% | शेयर |
| Grandeur Peak Global Advisors, LLC | $609572 | 14353 | 0.08% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $600441 | 14138 | 0.08% | शेयर |
| Walleye Partners, LLC | $572369 | 13477 | 0.07% | शेयर |
कंपनी के अंदरूनी सूत्र 20 इनसाइडर्स · 5 अधिकारी · 11 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Mark L. Baum | Chief Executive Officer | 10 फ़रवरी 2014 A | 1419835 | 0 | 0 | $0 |
| Juliet Singh | CEO, Director and President | 18 जून 2009 A | 1954125 | 0 | 0 | $0 |
| Andrew Boll | VP, Accounting and Reporting | 10 फ़रवरी 2014 A | — | 0 | 0 | $0 |
| Joachim Ph Schupp | CHIEF MEDICAL OFFICER | 1 अप्रैल 2013 A | — | 0 | 0 | $0 |
| Terry Nida | Chief Business Officer | 26 फ़रवरी 2010 A | — | 0 | 0 | $0 |
| Perry J. Sternberg | निदेशक | 18 जून 2026 A | — | 0 | 0 | $0 |
| Adrienne L Graves | निदेशक | 18 जून 2026 A | — | 0 | 0 | $0 |
| Lauren P Silvernail | निदेशक | 18 जून 2026 A | — | 0 | 0 | $0 |
| Peter C Kenny | निदेशक | 2 अक्टूबर 2013 A | 8947 | 0 | 0 | $0 |
| Robert J Kammer | निदेशक | 28 जून 2013 A | 931689 | 0 | 0 | $0 |
| August Shelby Bassani | निदेशक | 27 जून 2013 A | 6865 | 0 | 0 | $0 |
| Paul Finnegan | निदेशक | 27 जून 2013 A | 6865 | 0 | 0 | $0 |
| Jeffrey J Abrams | निदेशक | 27 जून 2013 A | 45927 | 0 | 0 | $0 |
| Stephen G Austin | निदेशक | 27 जून 2013 A | 6865 | 0 | 0 | $0 |
| DERMASTAR INTERNATIONAL, LLC | 10% मालिक | 12 जुलाई 2012 J | 0 | 0 | 0 | $0 |
| Amir Shojaei | — | 14 अगस्त 2026 M | 0 | 0 | 1 | $-450000 |
| John N Bonfiglio | — | 20 अक्टूबर 2010 A | 50000 | 0 | 0 | $0 |
| John T Lomoro | — | 19 जून 2009 A | — | 0 | 0 | $0 |
| Lynn C Swann | — | 21 नवमबर 2008 A | 25000 | 0 | 0 | $0 |
| Anthony S Thornley | — | 21 नवमबर 2008 A | 60900 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 5 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Mark L. Baum ×3 फाइलिंग | 7 अप्रैल 2025 | 10.69% | संशोधन | — | SEC |
| 27 अप्रैल 2021 | — | प्रारंभिक फाइलिंग | — | SEC | |
| Robert J. Kammer, as Trustee of The Robert J. Kammer Living Trust established 6/1/2000, Robert J. Kammer ×2 फाइलिंग | 30 अगस्त 2016 | — | प्रारंभिक फाइलिंग | — | SEC |
| Dr. Robert J. Kammer ×2 फाइलिंग | 16 अगस्त 2013 | — | प्रारंभिक फाइलिंग | — | SEC |
| DermaStar International, LLC ×7 फाइलिंग | 10 अगस्त 2012 | — | प्रारंभिक फाइलिंग | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 46 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1.47% | 4670 NS | 30 अप्रैल 2026 | N-PORT |
| IWC · iShares Trust | 0.29% | 109900 SH | 8 अगस्त 2026 | दैनिक |
| IHE · iShares Trust | 0.29% | 118464 SH | 8 अगस्त 2026 | दैनिक |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.26% | 66235 NS | 30 अप्रैल 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.10% | 2031 SH | 8 अगस्त 2026 | दैनिक |
| GSSC · Goldman Sachs ETF Trust | 0.10% | 28159 NS | 31 मई 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.08% | 48827 NS | 30 अप्रैल 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.08% | 34722 SH | 8 अगस्त 2026 | दैनिक |
| IWO · iShares Trust | 0.08% | 291642 SH | 8 अगस्त 2026 | दैनिक |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.07% | 19636 NS | 30 अप्रैल 2026 | N-PORT |
| BIB · ProShares Trust | 0.07% | 1370 NS | 31 मई 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.06% | 10343 NS | 30 अप्रैल 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.05% | 6175 NS | 30 अप्रैल 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.04% | 2997 SH | 8 अगस्त 2026 | दैनिक |
| IWM · iShares Trust | 0.04% | 824976 SH | 8 अगस्त 2026 | दैनिक |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 186298 SH | 8 अगस्त 2026 | दैनिक |
| RSSL · Global X Funds | 0.04% | 13694 NS | 30 अप्रैल 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.04% | 123278 NS | 30 अप्रैल 2026 | N-PORT |
| ISCG · iShares Trust | 0.03% | 8711 SH | 8 अगस्त 2026 | दैनिक |
| SMLF · iShares Trust | 0.03% | 33778 SH | 8 अगस्त 2026 | दैनिक |
| ITWO · ProShares Trust | 0.03% | 1486 NS | 31 मई 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.02% | 158672 NS | 31 मई 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 18041 NS | 31 मई 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 14677 NS | 30 अप्रैल 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 383679 SH | 8 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.02% | 94953 SH | 8 अगस्त 2026 | दैनिक |
| ISCB · iShares Trust | 0.02% | 1222 SH | 8 अगस्त 2026 | दैनिक |
| UWM · ProShares Trust | 0.02% | 1162 NS | 31 मई 2026 | N-PORT |
| WSML · iShares Trust | 0.01% | 2264 SH | 8 अगस्त 2026 | दैनिक |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.01% | 860 NS | 31 मई 2026 | N-PORT |
| URTY · ProShares Trust | 0.01% | 1174 NS | 31 मई 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 949 NS | 30 अप्रैल 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 1223 NS | 31 मई 2026 | N-PORT |
| EBI · RBB Fund Trust | 0.01% | 984 NS | 31 मई 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 18264 NS | 31 मई 2026 | N-PORT |
| HDG · ProShares Trust | 0.00% | 29 NS | 31 मई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 50366 NS | 30 अप्रैल 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.00% | 11315 NS | 31 मई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 8641 NS | 30 अप्रैल 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 1856 NS | 30 अप्रैल 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 11363 NS | 30 अप्रैल 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 45405 SH | 8 अगस्त 2026 | दैनिक |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 19602 NS | 31 मई 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 6962 SH | 8 अगस्त 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1001445 SH | 8 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2637 SH | 8 अगस्त 2026 | दैनिक |